A group mindfulness program for breast cancer survivors was compared with an education support program for cost-effectiveness. Over six months, the mindfulness program cost $5,744 per participant on average, while the education program cost $6,140. The mindfulness program dominated the education program in cost-utility analysis, saving $541 per participant while providing a small gain in quality-adjusted life years (0.021 QALY). Savings came mainly from fewer emergency room visits, hospital admissions, and tests. The mindfulness program had a higher probability of being cost-effective across a range of willingness-to-pay thresholds. The findings suggest the mindfulness program is likely cost-effective for breast cancer survivors.
A randomized clinical trial tested whether improvements in cognitive functioning and perceived cognitive abilities from a 6-week Mindfulness-Based Stress Reduction program for breast cancer survivors (MBSR[BC]) were mediated by increased mindfulness, decreased rumination, or decreased perceived stress. Among 212 breast cancer survivors (mean age 56.5, 73.1% White non-Hispanic), increases in the "observing" facet of mindfulness partially mediated MBSR(BC) effects on quality-of-life impairments and logical memory at 6 months compared to usual care. No mediation effects were found at 6 or 12 weeks, nor when MBSR(BC) was compared to a Breast Cancer Education Support program. The results partially support that cognitive improvements may occur through increased mindfulness.
A pilot study tested a mobile mindfulness-based stress reduction program (mMBSR(BC)) delivered via iPad to breast cancer survivors. Among 15 female survivors (stages 0-III) who had completed treatment, 13 completed the 6-week program. Significant improvements from baseline to week 6 were observed in depression, state anxiety, stress, fear of recurrence, sleep quality, fatigue, and quality of life, with medium to large effect sizes. The program appears feasible and acceptable, offering a convenient way to reduce symptom burden during survivorship.